High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
- PMID: 29100083
- PMCID: PMC5673604
- DOI: 10.1016/j.ajhg.2017.09.008
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
Abstract
Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental plateauing or regression associated with frequent epileptiform activity. The cause of DEE remains unknown in the majority of cases. We performed whole-genome sequencing (WGS) in 197 individuals with unexplained DEE and pharmaco-resistant seizures and in their unaffected parents. We focused our attention on de novo mutations (DNMs) and identified candidate genes containing such variants. We sought to identify additional subjects with DNMs in these genes by performing targeted sequencing in another series of individuals with DEE and by mining various sequencing datasets. We also performed meta-analyses to document enrichment of DNMs in candidate genes by leveraging our WGS dataset with those of several DEE and ID series. By combining these strategies, we were able to provide a causal link between DEE and the following genes: NTRK2, GABRB2, CLTC, DHDDS, NUS1, RAB11A, GABBR2, and SNAP25. Overall, we established a molecular diagnosis in 63/197 (32%) individuals in our WGS series. The main cause of DEE in these individuals was de novo point mutations (53/63 solved cases), followed by inherited mutations (6/63 solved cases) and de novo CNVs (4/63 solved cases). De novo missense variants explained a larger proportion of individuals in our series than in other series that were primarily ascertained because of ID. Moreover, these DNMs were more frequently recurrent than those identified in ID series. These observations indicate that the genetic landscape of DEE might be different from that of ID without epilepsy.
Keywords: CLTC; DHDDS; GABBR2; GABRB2; NTRK2; NUS1; RAB11; SNAP25; epileptic encephalopathy.
Copyright © 2017 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Alphabet Soup: Recurrent De Novo Mutations in Novel Genes Causing Developmental and Epileptic Encephalopathies.Epilepsy Curr. 2018 Mar-Apr;18(2):125-127. doi: 10.5698/1535-7597.18.2.125. Epilepsy Curr. 2018. PMID: 29671845 Free PMC article. No abstract available.
Similar articles
-
A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy.Am J Med Genet A. 2021 Nov;185(11):3384-3389. doi: 10.1002/ajmg.a.62455. Epub 2021 Aug 27. Am J Med Genet A. 2021. PMID: 34448338
-
A Chinese patient with developmental and epileptic encephalopathies (DEE) carrying a TRPM3 gene mutation: a paediatric case report.BMC Pediatr. 2021 Jun 1;21(1):256. doi: 10.1186/s12887-021-02719-8. BMC Pediatr. 2021. PMID: 34074259 Free PMC article.
-
Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.Am J Med Genet A. 2020 Apr;182(4):713-720. doi: 10.1002/ajmg.a.61483. Epub 2020 Jan 11. Am J Med Genet A. 2020. PMID: 31926053
-
Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.Epilepsia. 2014 Apr;55(4):e25-9. doi: 10.1111/epi.12554. Epub 2014 Mar 1. Epilepsia. 2014. PMID: 24579881 Review.
-
De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review.Seizure. 2023 Oct;111:138-146. doi: 10.1016/j.seizure.2023.08.009. Epub 2023 Aug 18. Seizure. 2023. PMID: 37633153 Review.
Cited by
-
Cys-loop receptors on cannabinoids: All high?Front Physiol. 2022 Nov 9;13:1044575. doi: 10.3389/fphys.2022.1044575. eCollection 2022. Front Physiol. 2022. PMID: 36439263 Free PMC article.
-
Structural basis of the activation of a metabotropic GABA receptor.Nature. 2020 Aug;584(7820):298-303. doi: 10.1038/s41586-020-2408-4. Epub 2020 Jun 17. Nature. 2020. PMID: 32555460 Free PMC article.
-
From Genotype to Phenotype: Expanding the Clinical Spectrum of CACNA1A Variants in the Era of Next Generation Sequencing.Front Neurol. 2021 Mar 2;12:639994. doi: 10.3389/fneur.2021.639994. eCollection 2021. Front Neurol. 2021. PMID: 33737904 Free PMC article. Review.
-
Family-Based Genome-Wide Association Study of Autism Spectrum Disorder in Middle Eastern Families.Genes (Basel). 2021 May 18;12(5):761. doi: 10.3390/genes12050761. Genes (Basel). 2021. PMID: 34069769 Free PMC article.
-
SNAP25 disease mutations change the energy landscape for synaptic exocytosis due to aberrant SNARE interactions.Elife. 2024 Feb 27;12:RP88619. doi: 10.7554/eLife.88619. Elife. 2024. PMID: 38411501 Free PMC article.
References
-
- Berg A.T., Langfitt J.T., Testa F.M., Levy S.R., DiMario F., Westerveld M., Kulas J. Global cognitive function in children with epilepsy: a community-based study. Epilepsia. 2008;49:608–614. - PubMed
-
- Tuchman R., Cuccaro M. Epilepsy and autism: neurodevelopmental perspective. Curr. Neurol. Neurosci. Rep. 2011;11:428–434. - PubMed
-
- Shepherd C., Hosking G. Epilepsy in school children with intellectual impairments in Sheffield: the size and nature of the problem and the implications for service provision. J. Ment. Defic. Res. 1989;33:511–514. - PubMed
-
- Ben-Ari Y., Holmes G.L. Effects of seizures on developmental processes in the immature brain. Lancet Neurol. 2006;5:1055–1063. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
